Home › Medicines › Spark
বাংলায় দেখুন
💊

Spark

Tablet

🧬 Sparfloxacin 🏢 Navana Pharmaceuticals Ltd.
Generic Name Sparfloxacin
Manufacturer Navana Pharmaceuticals Ltd.
Unit Price Unit Price: ৳ 15.05 (1 x 10: ৳ 150.50) Strip Price: ৳ 150.50

🔹 Indications

Spark is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Spark is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Pharmacology

Spark is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Spark is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Dosage & Administration

Spark is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Spark is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Interaction

Spark is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Spark is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Contraindications

Spark is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Spark is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Side Effects

Spark is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Spark is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Pregnancy & Lactation

Spark is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Spark is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Precautions & Warnings

Spark is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:
  • Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
  • Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.
Spark is also indicated for-
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Maxillary Sinusitis (AMS)
  • Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
  • Bacterial prostatitis.
  • Bacterial diarrhoea
  • Osteomyelitis
  • Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔍 People also search for

Spark Spark Tablet used for Spark side effects Spark price Spark dose Spark Tablet uses Is Spark safe Spark dosage Spark alternative Spark Bangladesh Sparfloxacin Sparfloxacin price Bangladesh Tablet price Bangladesh Navana Pharmaceuticals Ltd. medicine bd

💡 Frequently Asked Questions

Spark is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae...
Spark is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae...
Spark is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae...

User Reviews

⭐
No reviews yet!
Be the first to share your experience.

Write a Review

Alternative Medicines
(Same Generic)

Floxipar Tablet

ACME Laboratories Ltd.

Unit Price: ৳ 15.61 (1 x 10: ৳ 156.10) Strip Price: ৳ 156.10

Aciflox Tablet

ACI Limited

Unit Price: ৳ 12.00 (1 x 10: ৳ 120.00) Strip Price: ৳ 120.00

Mega Flox Tablet

Hudson Pharmaceuticals Ltd.

Unit Price: ৳ 15.00 (20's pack: ৳ 300.00)

Piocin Tablet

Millat Pharmaceuticals Ltd.

Unit Price: ৳ 18.00 (6's pack: ৳ 108.00)

Saga Tablet

Square Pharmaceuticals PLC

Unit Price: ৳ 15.05 (3 x 5: ৳ 225.75) Strip Price: ৳ 75.25

Salocin Tablet

Kemiko Pharmaceuticals Ltd.

Unit Price: ৳ 17.05 (10's pack: ৳ 170.50)

Spacin Tablet

SANDOZ (A Novartis Division)

Unit Price: ৳ 26.00 (1 x 10: ৳ 260.00) Strip Price: ৳ 260.00

Spalox Tablet

Edruc Limited

Unit Price: ৳ 16.00 (10's pack: ৳ 160.00)

Spar Tablet

Globe Pharmaceuticals Ltd.

Unit Price: ৳ 20.00 (1 x 10: ৳ 200.00) Strip Price: ৳ 200.00

Salocin Tablet

Kemiko Pharmaceuticals Ltd.

Unit Price: ৳ 17.05 (10's pack: ৳ 170.50)